MedPath

Carbetocin vs Oxytocin for prevention of blood loss after normal vaginal delivery

Phase 3
Registration Number
CTRI/2023/06/053901
Lead Sponsor
Maharaja Agrasen Medical College, Agroha,Hisar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. They are beyond 32 weeks of gestational age

2. They have singleton pregnancy.

3. They present with cephalic presentation.

4. They have at least one risk factor for PPH of the following

-Uterine over-distention (Polyhydramnios, suspected macrosomia)

-Maternal disorders (Hypertensive disorders, Anaemia)

-Prolonged Labour (more than 12 hours of labour in combined 1st and 2nd stage of labour)

-Grand multipara

-Primipara

-Induction of labour

Exclusion Criteria

1. Operative vaginal deliveries

2.Causes of traumatic PPH (Extensive vaginal lacerations,cervical tears)

3. patients with serious medical disorders like cardiovascular disorders, hepatic disorders, renal disorders, epilepsy, and coagulation disorders.

4. Known allergies to carbetocin or oxytocin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
proportion of cases with blood loss more than 500 ml in first 24 hours postpartum after primary intervention.(Carbetocin or Oxytocin)Timepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
Proportion of cases needing additional uterotonicsafter primary intervention in first 24 hours postpartum.Timepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath